Autism Research Program
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social communication and the presence of repetitive behaviors and restricted interests. The prevalence of ASD has been rising steadily over the past 10 years, with recent estimates that 1/68 children have ASD (CDC, 2014).
Dr. Suma Jacob’s research lab conducts studies that examine effects of novel interventions on social functioning and repetitive behaviors for both children and adults.
There are currently no approved medications specific for social behaviors in autism. Recently, several investigational drugs are being studied because of their potential to improve social functioning and restrictive, repetitive behaviors in individuals with autism. Please visit our specific studies below to learn more.
Focus in NeuroDevelopment Network
Participants: Children and Adults
A Pilot Multimodal Brain Connectivity Study of Autism Spectrum Disorder
Participants: Ages 8-17
Intranasal Oxytocin for the Treatment of Children and Adolescents with Autism Spectrum Disorders (ASD)
Participants: Ages 10-17
Single Dose Intranasal Oxytocin (IN-OT) Versus Placebo in Autism: Examining the Cognitive Effects
Participants: Ages 5-40
Participants: Ages 12-17 males
Participants: Ages 18-45 males
- Autism Research Program
- Bipolar Disorder Research
- Center for Adolescent Substance Abuse Research (CASAR)
- Child & Adolescent Anxiety Research
- Child & Adolescent Mood Disorders Research
- Psychotic Disorders Research
- The Minnesota Center for Eating Disorders Research
Research ethics at the University of Minnesota
We are committed to protecting research participants, upholding ethical standards, and improving our practice at every step of our work.